These findings suggest that nuclear alpha-synuclein plays a role in promoting nigrostriatal degeneration in Parkinson’s disease and support further investigation into histone deacetylase inhibitors as potential therapeutic options for the disorder [76,77]. The gene discussed is SNCA; the disease is Parkinson disease.